HCPCS codes

22721 HCPCS codes with hospital pricing data in the network.

• HCPCS J9026 — Tarlatamab-dlle injection, per 1 mgAI (1426 hospitals, 562–1,363 samples)
• HCPCS J9276 — Zanidatamab injection, per 2 mgAI (972 hospitals, 1,351–1,360 samples)
• HCPCS J9021 — Rylaze asparaginase injection, per 0.1 mgAI (1335 hospitals, 1,229–1,355 samples)
• HCPCS J0587 — Rimabotulinumtoxin B injection, 100 unitsAI (1424 hospitals, 1,280–1,352 samples)
• HCPCS A0433 — Advanced life support, level 2 ambulance transportAI (795 hospitals, 289–1,342 samples)
• HCPCS Q0224 — Pemivibart injection for COVID-19 pre-exposure prophylaxisAI (1216 hospitals, 1,097–1,331 samples)
• HCPCS S0028 — Famotidine injection, 20 mgAI (694 hospitals, 891–1,305 samples)
• HCPCS Q5157 — Denosumab biosimilar injection, per milligramAI (764 hospitals, 782–1,304 samples)
• HCPCS G0316 — Prolonged inpatient evaluation, additional 15 minutesAI (792 hospitals, 835–1,303 samples)
• HCPCS A9548 — Indium-111 pentetate diagnostic tracerAI (1876 hospitals, 172–1,297 samples)
• HCPCS L1810 — Knee brace with hinged jointsAI (1270 hospitals, 351–1,296 samples)
• HCPCS J0895 — Deferoxamine mesylate 500 mg injectionAI (2079 hospitals, 407–1,289 samples)
• HCPCS A0998 — Ambulance response and treatment feeAI (437 hospitals, 623–1,280 samples)
• HCPCS J0180 — Injection of agalsidase beta, per milligramAI (1578 hospitals, 1,017–1,278 samples)
• HCPCS J9319 — Romidepsin injection, 0.1 mgAI (1525 hospitals, 1,121–1,265 samples)
• HCPCS J2690 — Procainamide hydrochloride injectionAI (2120 hospitals, 237–1,245 samples)
• HCPCS J0289 — Amphotericin B liposome injection, 50 mgAI (2086 hospitals, 1,076–1,238 samples)
• HCPCS J1322 — Injection of elosulfase alfa, per 1 mgAI (1227 hospitals, 1,224 samples)
• HCPCS H2012 — Behavioral health day treatment, per hourAI (392 hospitals, 1,091–1,217 samples)
• HCPCS J1932 — Lanreotide injection, 1 mgAI (1414 hospitals, 778–1,210 samples)
• HCPCS C9088 — Zynrelef extended-release pain relief medicationAI (912 hospitals, 553–1,210 samples)
• HCPCS V2521 — Toric or prism ballast hydrophilic contact lensAI (783 hospitals, 121–1,210 samples)
• HCPCS A4357 — Bedside urinary drainage bagAI (865 hospitals, 120–1,200 samples)
• HCPCS S4993 — Norethindrone and ethinyl estradiol oral tabletAI (687 hospitals, 120–1,200 samples)
• HCPCS C1605 — Leadless pacemaker systemAI (835 hospitals, 144–1,197 samples)
• HCPCS J0525 — Cefotetan 1 gram injectionAI (519 hospitals, 520–1,186 samples)
• HCPCS L3919 — Custom hand brace without joints, fittedAI (1356 hospitals, 203–1,184 samples)
• HCPCS L8501 — Tracheostomy speaking valveAI (1690 hospitals, 118–1,180 samples)
• HCPCS G0537 — Cardiovascular disease risk assessment, 5-15 minutesAI (821 hospitals, 537–1,176 samples)
• HCPCS C1052 — Endoscopic powder system to stop upper GI bleedingAI (1245 hospitals, 116–1,160 samples)
• HCPCS A6211 — Large sterile foam wound dressing without adhesive borderAI (906 hospitals, 188–1,160 samples)
• HCPCS Q5133 — Tocilizumab-bavi (Tofidence) injection, per 1 mgAI (1211 hospitals, 1,126–1,144 samples)
• HCPCS P9022 — Washed red blood cells, one unitAI (1841 hospitals, 307–1,144 samples)
• HCPCS V5140 — Behind-the-ear binaural hearing aidAI (464 hospitals, 114–1,140 samples)
• HCPCS C9290 — Exparel (bupivacaine liposome) injectionAI (619 hospitals, 415–1,135 samples)
• HCPCS J1300 — Soliris (eculizumab) 300 mg IV infusionAI (1012 hospitals, 1,053–1,134 samples)
• HCPCS A7048 — Vacuum drainage collection unit and tubing kitAI (961 hospitals, 113–1,130 samples)
• HCPCS B4082 — Nasogastric feeding tube without styletAI (795 hospitals, 113–1,130 samples)
• HCPCS L3999 — Upper limb orthosis, not otherwise specifiedAI (734 hospitals, 188–1,124 samples)
• HCPCS V2599 — Other type of contact lensAI (305 hospitals, 161–1,124 samples)
• HCPCS J2184 — Injection of meropenem antibiotic, 100 mgAI (1262 hospitals, 952–1,123 samples)
• HCPCS Q0161 — Chlorpromazine 50 mg oral tabletAI (1204 hospitals, 128–1,118 samples)
• HCPCS C9601 — Additional coronary stent placement in a second artery branchAI (1798 hospitals, 135–1,116 samples)
• HCPCS C1756 — Transesophageal pacing catheterAI (548 hospitals, 338–1,112 samples)
• HCPCS A6199 — Gel-fiber wound dressing, 0.75 x 18 inchesAI (964 hospitals, 246–1,092 samples)
• HCPCS J3385 — Velaglucerase alfa injection for Gaucher diseaseAI (1297 hospitals, 965–1,091 samples)
• HCPCS A6402 — Sterile gauze pad, 16 sq. in. or smaller, no adhesive borderAI (774 hospitals, 537–1,086 samples)
• HCPCS J0401 — Aripiprazole injection (Abilify Maintena), per 1 mgAI (1632 hospitals, 654–1,077 samples)
• HCPCS J0740 — Injection of cidofovir, 375 mgAI (1685 hospitals, 698–1,076 samples)
• HCPCS J9027 — Clofarabine injection, per 1 mgAI (1443 hospitals, 1,070 samples)